Michal Janowski
Szczecin, ZP 70111, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Depth of the Molecular Response in Patients with Chronic Myeloid Leukemia Correlates with Changes in Humoral Immunity.
Journal: Journal of clinical medicine
Published: March 12, 2024
High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.
Journal: Journal of applied genetics
Published: June 11, 2023
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
Journal: Journal of cancer research and clinical oncology
Published: June 14, 2022
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.
Journal: OncoTargets and therapy
Published: May 11, 2022
Case of Patient with AML with Complex Karyotype including Ultra-Rare t(4;8)(q32;q13), t(4;11)(q21;p15) and Familial Aggregation of Myeloid Malignancies.
Journal: Medicina (Kaunas, Lithuania)
Published: November 29, 2021
The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma.
Journal: Journal of clinical medicine
Published: September 07, 2021
Hodgkin Lymphoma as a Secondary Neoplasm During Therapy for Chronic Myeloid Leukaemia: Case Report and Review of the Literature.
Journal: OncoTargets and therapy
Published: January 18, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026